Doctor profile · Federal record
Dr. George Dobo, Medical Doctor
Dermatology Physician (CMS: Dermatology) · Powder Springs, GA
- NPI 1689631434
- Accepts Medicare
- MIPS 88.1 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5041 Dallas Hwy, Ste D
Powder Springs, GA 30127
(770) 427-5467
fax (770) 427-6340 - Mailing address
-
111 Marble Mill RD Nw
Marietta, GA 300601047
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- December 6, 2011
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Georgia #047734
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689631434. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,264
Distinct HCPCS
10
Medicare allowed
$474,605
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,380 | 510 | $7 | |
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3,200 | 16 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,050 | 832 | $89 | |
17000 |
Destruction of precancer skin growth, 1 growth | 832 | 646 | $47 | |
17110 |
Destruction of skin growth, 1-14 growths | 787 | 629 | $112 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 564 | 438 | $125 | |
11102 |
Biopsy of related skin growth, first growth | 337 | 310 | $84 | |
96900 |
Application of ultraviolet light to skin | 265 | 31 | $24 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 185 | 126 | $168 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 126 | 122 | $56 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 489. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$1,241
Transactions
59
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $245.20 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $203.86 | |
| Janssen Biotech, Inc. | 7 | $136.94 | |
| ABBVIE INC. | 10 | $135.16 | |
| Amgen Inc. | 5 | $118.60 | |
| Arcutis Biotherapeutics, Inc. | 6 | $103.89 | |
| Kerecis Limited | 1 | $103.14 | |
| Dermavant Sciences, Inc. | 3 | $67.58 | |
| GENZYME CORPORATION | 1 | $52.36 | |
| Galderma Laboratories, L.P. | 2 | $33.52 | |
| PFIZER INC. | 1 | $23.83 | |
| UCB, Inc. | 1 | $17.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,391
Patients
839
Total drug cost
$47,974
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocortisone | Generic | 351 | 244 | $1,695 |
| Clobetasol Propionate | Generic | 280 | 160 | $16,601 |
| Triamcinolone Acetonide | Generic | 210 | 145 | $3,015 |
| Ketoconazole | Generic | 151 | 84 | $4,512 |
| Doxycycline Hyclate | Generic | 95 | 56 | $7,399 |
| Metronidazole | Generic | 71 | 43 | $5,091 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 43 | 22 | $1,074 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 39 | 18 | $3,490 |
| Prednisone | Generic | 28 | 19 | $147 |
| Fluticasone Propionate | Generic | 27 | 18 | $692 |
Frequently asked questions
What is Dr. George Dobo's medical specialty?
Dr. George Dobo practices Dermatology Physician in Powder Springs, GA.
Where does Dr. George Dobo practice?
Dr. George Dobo practices at 5041 Dallas Hwy, Powder Springs, GA 30127. Office phone: 7704275467.
What is Dr. George Dobo's NPI?
Dr. George Dobo's National Provider Identifier (NPI) is 1689631434, issued by NPPES.
Does Dr. George Dobo accept Medicare assignment?
Yes. Dr. George Dobo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. George Dobo commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.